A major clinical trial involving nearly 5,800 adults has challenged conventional approaches to determining which patients require statin therapy, researchers report. The study found that using heart scans to measure calcium buildup in the arteries produced the same observed rate of major cardiovascular events as traditional risk assessments, despite recommending statins to substantially fewer patients. The findings suggest that coronary artery calcium scoring may offer a more targeted method of identifying individuals at genuine risk, potentially sparing many patients from unnecessary long-term medication while achieving comparable health outcomes across the study population.
Perhaps the most striking result concerned patient behavior. Participants advised to take statins on the basis of their scan results were nearly three times as likely to adhere to their medication compared with those following traditional risk assessments. Researchers suggest the visual evidence of calcium deposits may make the threat of heart disease more tangible, strengthening patient commitment to treatment. The trial raises important questions about how physicians should balance population-wide risk models against individualized imaging, and whether better adherence among fewer patients could reshape clinical guidelines for cardiovascular prevention. Further analysis is expected as clinicians weigh the implications.
Independent reporting synthesized from primary wires and global correspondents.